C Scape

Drug Profile

C Scape

Alternative Names: ACHN 383; ACHN 383 and AHN 789; ACHN 789; C-Scape

Latest Information Update: 14 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Achaogen
  • Class Antibacterials; Beta-lactams
  • Mechanism of Action Beta lactamase inhibitors; Cell wall inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Urinary tract infections

Most Recent Events

  • 01 Jun 2017 Phase-I clinical trials in Urinary tract infections in Australia (PO) (NCT03163550)
  • 01 Mar 2017 Achaogen plans a phase I trial for Urinary tract infections in USA in the second quarter of 2017
  • 01 Mar 2017 Achaogen plans a phase III trial for Urinary tract infections in USA in the first half of 2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top